Literature DB >> 16155196

Genotype-phenotype relationship in hereditary haemorrhagic telangiectasia.

T G W Letteboer, J J Mager, R J Snijder, B P C Koeleman, D Lindhout, J K Ploos van Amstel, C J J Westermann.   

Abstract

Hereditary haemorrhagic telangiectasia (HHT) is an autosomal dominant disorder characterised by vascular malformations in multiple organ systems, resulting in mucocutaneous telangiectases and arteriovenous malformations predominantly in the lungs (pulmonary arteriovenous malformation; PAVM), brain (cerebral arteriovenous malformation; CAVM), and liver (hepatic arteriovenous malformation; HAVM). Mutations in the ENG and ALK-1 genes lead to HHT1 and HHT2 respectively. In this study, a genotype-phenotype analysis was performed. A uniform and well classified large group of HHT patients and their family members were screened for HHT manifestations. Groups of patients with a clinically confirmed diagnosis and/or genetically established diagnosis (HHT1 or HHT2) were compared. The frequency of PAVM, CAVM, HAVM, and gastrointestinal telangiectases were determined to establish the genotype-phenotype relationship. The analysis revealed differences between HHT1 and HHT2 and within HHT1 and HHT2 between men and women. PAVMs and CAVMs occur more often in HHT1, whereas HAVMs are more frequent in HHT2. Furthermore, there is a higher prevalence of PAVM in women compared with men in HHT1. In HHT1 and HHT2, there is a higher frequency of HAVM in women. HHT1 has a distinct, more severe phenotype than HHT2. There is a difference in the presence of symptoms between men and women. With these data, genetic counselling can be given more accurately when the family mutation is known.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16155196      PMCID: PMC2563220          DOI: 10.1136/jmg.2005.035451

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  29 in total

1.  A new locus for hereditary haemorrhagic telangiectasia (HHT3) maps to chromosome 5.

Authors:  S G Cole; M E Begbie; G M F Wallace; C L Shovlin
Journal:  J Med Genet       Date:  2005-07       Impact factor: 6.318

2.  Unusual complications after embolization of a pulmonary arteriovenous malformation.

Authors:  T Haitjema; J M ten Berg; T T Overtoom; J M Ernst; C J Westermann
Journal:  Chest       Date:  1996-05       Impact factor: 9.410

Review 3.  Hereditary hemorrhagic telangiectasia.

Authors:  A E Guttmacher; D A Marchuk; R I White
Journal:  N Engl J Med       Date:  1995-10-05       Impact factor: 91.245

4.  Disease-associated mutations in conserved residues of ALK-1 kinase domain.

Authors:  Salma A Abdalla; Urszula Cymerman; Rachel M Johnson; Charles M Deber; Michelle Letarte
Journal:  Eur J Hum Genet       Date:  2003-04       Impact factor: 4.246

5.  Visceral manifestations in hereditary haemorrhagic telangiectasia type 2.

Authors:  S A Abdalla; U W Geisthoff; D Bonneau; H Plauchu; J McDonald; S Kennedy; M E Faughnan; M Letarte
Journal:  J Med Genet       Date:  2003-07       Impact factor: 6.318

6.  Hereditary haemorrhagic telangiectasia: a questionnaire based study to delineate the different phenotypes caused by endoglin and ALK1 mutations.

Authors:  J Berg; M Porteous; D Reinhardt; C Gallione; S Holloway; T Umasunthar; A Lux; W McKinnon; D Marchuk; A Guttmacher
Journal:  J Med Genet       Date:  2003-08       Impact factor: 6.318

7.  Pulmonary arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia.

Authors:  Vincent Cottin; Henri Plauchu; Jean-Yves Bayle; Martine Barthelet; Didier Revel; Jean-François Cordier
Journal:  Am J Respir Crit Care Med       Date:  2004-01-23       Impact factor: 21.405

8.  Molecular screening of ALK1/ACVRL1 and ENG genes in hereditary hemorrhagic telangiectasia in France.

Authors:  Gaëtan Lesca; Henri Plauchu; Florence Coulet; Sylvain Lefebvre; Ghislaine Plessis; Sylvie Odent; Sophie Rivière; Bruno Leheup; Cyril Goizet; Marie-France Carette; Jean-François Cordier; Stéphane Pinson; Florent Soubrier; Alain Calender; Sophie Giraud
Journal:  Hum Mutat       Date:  2004-04       Impact factor: 4.878

9.  A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4).

Authors:  Carol J Gallione; Gabriela M Repetto; Eric Legius; Anil K Rustgi; Susan L Schelley; Sabine Tejpar; Grant Mitchell; Eric Drouin; Cornelius J J Westermann; Douglas A Marchuk
Journal:  Lancet       Date:  2004-03-13       Impact factor: 79.321

10.  Screening family members of patients with hereditary hemorrhagic telangiectasia.

Authors:  T Haitjema; F Disch; T T Overtoom; C J Westermann; J W Lammers
Journal:  Am J Med       Date:  1995-11       Impact factor: 4.965

View more
  80 in total

1.  Basal Ganglia T1 Hyperintensity in Hereditary Hemorrhagic Telangiectasia.

Authors:  A Parvinian; V N Iyer; B S Pannu; D R Apala; C P Wood; W Brinjikji
Journal:  AJNR Am J Neuroradiol       Date:  2017-08-03       Impact factor: 3.825

2.  An unusual cause of hemoptysis in a young female.

Authors:  Pankaj Gupta; Raju Sharma; Surendra K Sharma
Journal:  Oman Med J       Date:  2011-11

Review 3.  Familial occurrence of brain arteriovenous malformations: a systematic review.

Authors:  J van Beijnum; H B van der Worp; H M Schippers; O van Nieuwenhuizen; L J Kappelle; G J E Rinkel; J W Berkelbach van der Sprenkel; C J M Klijn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-01-26       Impact factor: 10.154

4.  Integrin β8 Deletion Enhances Vascular Dysplasia and Hemorrhage in the Brain of Adult Alk1 Heterozygous Mice.

Authors:  Li Ma; Fanxia Shen; Kristine Jun; Chen Bao; Robert Kuo; William L Young; Stephen L Nishimura; Hua Su
Journal:  Transl Stroke Res       Date:  2016-06-29       Impact factor: 6.829

5.  The ACVRL1 c.314-35A>G polymorphism is associated with organ vascular malformations in hereditary hemorrhagic telangiectasia patients with ENG mutations, but not in patients with ACVRL1 mutations.

Authors:  Ludmila Pawlikowska; Jeffrey Nelson; Diana E Guo; Charles E McCulloch; Michael T Lawton; William L Young; Helen Kim; Marie E Faughnan
Journal:  Am J Med Genet A       Date:  2015-04-02       Impact factor: 2.802

6.  Directional next-generation RNA sequencing and examination of premature termination codon mutations in endoglin/hereditary haemorrhagic telangiectasia.

Authors:  F S Govani; A Giess; I G Mollet; M E Begbie; M D Jones; L Game; C L Shovlin
Journal:  Mol Syndromol       Date:  2013-04-11

7.  Polymorphisms in ACVRL1 and endoglin genes are not associated with sporadic and HHT-related brain AVMs in Dutch patients.

Authors:  Kim Boshuisen; Manon Brundel; Carolien G F de Kovel; Tom G Letteboer; Gabriel J E Rinkel; Cornelis J J Westermann; Helen Kim; Ludmila Pawlikowska; Bobby P C Koeleman; Catharina J M Klijn
Journal:  Transl Stroke Res       Date:  2012-11-29       Impact factor: 6.829

8.  Hepatic sonography in patients with hereditary hemorrhagic telangiectasia hospitalized for epistaxis.

Authors:  F Draghi; A Presazzi; G M Danesino; N de Matthaeis; G L Rapaccini; C Danesino
Journal:  J Ultrasound       Date:  2012-04-20

9.  Vascular injury triggers Krüppel-like factor 6 mobilization and cooperation with specificity protein 1 to promote endothelial activation through upregulation of the activin receptor-like kinase 1 gene.

Authors:  Eva M Garrido-Martín; Francisco J Blanco; Mercé Roquè; Laura Novensà; Mirko Tarocchi; Ursula E Lang; Toru Suzuki; Scott L Friedman; Luisa M Botella; Carmelo Bernabéu
Journal:  Circ Res       Date:  2012-10-09       Impact factor: 17.367

10.  Mutation analysis of "Endoglin" and "Activin receptor-like kinase" genes in German patients with hereditary hemorrhagic telangiectasia and the value of rapid genotyping using an allele-specific PCR-technique.

Authors:  Haneen Sadick; Johanna Hage; Ulrich Goessler; Jens Stern-Straeter; Frank Riedel; Karl Hoermann; Peter Bugert
Journal:  BMC Med Genet       Date:  2009-06-09       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.